Background/Aims: Raddeanin A (RA), an active pharmacological ingredient from Anemone raddeana Regel, plays an important role in tumor suppression. In this study, we assessed the potentially therapeutic effect of RA on glioblastoma and its underlying mechanisms. Methods: Cell viability was examined using the MTT assay. Invasive and migratory capacities were examined using Transwell and wound healing assays. Apoptosis was determined by Hoechst staining, flow cytometry, DCFH-fluorescent probe and immunohistochemical staining. Autophagy was detected by transmission electron microscopy and western blotting. A U251 glioma xenograft model was established to evaluate the effect of RA in vivo. Results: The data demonstrated that RA inhibited viability, and abrogated the invasive/migratory abilities of glioblastoma cells. In addition, RA induced apoptosis by reactive oxygen species (ROS)/ Jun N-terminal kinase (JNK) signaling in glioblastoma. Conversely, the antioxidant N-Acetyl-L-cysteine (NAC) and pan-caspase inhibitor z-VAD-fmk attenuated RA-induced apoptosis by scavenging ROS and inactivating caspase-3. Furthermore, the inhibition of autophagy by 3-MA exacerbated apoptosis through ROS generation and JNK phosphorylation. In vivo, RA exhibited a curative effect on U251-derived xenografts in nude mice. Conclusions: The results of this study suggest that RA suppressed the growth of glioblastoma, thus serving as a promising and potential strategy for glioblastoma chemotherapy.
Introduction
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults and has high morbidity and mortality [1] . Despite optimal treatment, the highly invasive/migratory capacity of tumor cells and difficulty in achieving complete surgical resection result in a median survival of less than two years after diagnosis [2, 3] . One of the most important hallmarks of tumor cells is resistance to cell death [4] . Consequently, preferable therapeutic regimens and strategies are in urgent need to eradicate glioblastoma.
Natural products from traditional Chinese herbs used in the treatment of malignant tumors have a long history and are currently attracting increasing attention from researchers worldwide [5, 6] . Our previous studies have demonstrated the prominent effect of arsenic trioxide (ATO) in inhibiting the stemness of glioma stem cells (GSCs) by downregulating Notch signaling [7, 8] . Raddeanin A (RA), an active extraction from the root of the traditional Chinese medicinal herb Anemone raddeana Regel [9] , plays an important role in suppressing tumors (Fig. 1A) . Xue et al. demonstrated that RA inhibited invasion and induced apoptosis in human gastric cancer cell lines, including BGC-823, SGC-7901 and MKN-28 [10] . Guan et al. reported that RA suppressed angiogenesis by inhibiting VEGFR2 signaling in human colorectal tumors [11] . However, the exact effect of RA on glioblastoma remains unclear.
Apoptosis and autophagy are involved in numerous pathological processes and affect each other [12] . Clinicians and researchers continually focus on ameliorating the prognosis of patients with malignancies by inducing the apoptosis of malignant cells [13, 14] . Autophagy is a conserved pathway of lysosomal degradation, which is characterized by autophagosome formation [15] . The resulting catabolic process primarily functions to refuel cells under conditions of dysfunctional metabolic building during a stressful stimulation [16] . However, under certain conditions, excessive autophagy may result in cell death, or apoptosis [17, 18] . Accumulating evidence has demonstrated that resistance to apoptosis in cancer cells can be reversed by autophagy [19, 20] .
ROS (reactive oxygen species) is primarily produced in the mitochondria [21] and has been associated with solid tumors [22] . Accumulating evidence suggests that cancer cells are usually under increased stressful conditions and are therefore more vulnerable to damage from further insults induced by anticancer drugs [23] . Furthermore, ROS can regulate various signaling pathways, including the mitogen-activated protein kinase (MAPK) signal transduction cascade [24] . c-Jun N-terminal kinase (JNK) is a member of the MAPK family, and is associated with the regulation of cell proliferation, survival and differentiation [25] . Recent studies have demonstrated that JNK is involved in mediating the apoptotic response of cells to pro-inflammatory cytokines and environmental stresses in most cases [26, 27] . Meanwhile, ROS has been demonstrated to be involved in the regulation of apoptosis [28] and the sustained phosphorylation of JNK (p-JNK) [24] . However, the relationship between RA and apoptosis in GBM as well as the involvement of ROS production and p-JNK remain unclear.
USA) supplemented with 10% FBS (Excell Biology Inc., China) and 1% penicillin/streptomycin solution (Gibco, USA), and were maintained in a humidified incubator containing 5% CO 2 at 37 °C.
MTT assay
Cells were seeded in 96-well plates at a density of 5-8×10 4 cells/mL, followed by exposure to RA at the indicated concentrations (0-8 μM) for different times (0-48 h). After adding 10 μL/well of MTT solution (5 mg/mL), the dishes were incubated at 37 °C for 4 h. Next, formazan crystals were solubilized using 150 μL/ well DMSO, and absorbance was measured at 570 nm by a microplate reader (M200; TECAN, Switzerland).
Wound healing assay
For the assessment of migration, 1×10
5 cells were seeded in 3.5-cm dishes and cultured until they reached 90% confluence. A wound was made by manually scratching the monolayer with a sterilized 200-μL pipette tip, and then the medium was replaced with fresh DMEM supplemented with 0.5% FBS. Cell migration into the wound was observed in nine random microscopic fields for each drug concentration and time point using a digital imaging system (DP21; Olympus, Japan).
Transwell assay
The invasive and migratory capacities of glioma cells were investigated by Transwell assay as previously described [29] . Cells were seeded in 24-well plates with 8-μm pore Transwell chambers (Corning, USA). The membrane was coated with 80 μL Matrigel (BD) to measure invasiveness or no Matrigel to measure migration. For the invasion assay, 5×10 4 cells suspended in serum-free DMEM were seeded into the upper chamber, and medium containing serum was added into the bottom chamber as a chemoattractant. For the migration assay, cells were suspended in serum-free medium and then added to the upper chamber, and medium without FBS was used in the bottom chamber. Following treatment, the cells with non-invasive or non-migratory capacities were swabbed. The invading and migrating cells that attached to the underside of the polycarbonate membrane surface were stained with 0.1% crystal violet for 30 min, air-dried, washed, and then counted using a digital imaging system (DP21). Six random fields were selected, and the mean number of cells per field was calculated.
Protein extraction and western blot analysis
Protein extraction and western blotting were performed as previously described [30] . In brief, 3×10 5 cells were seeded in 6-cm dishes and exposed to RA (0-6 μM) at different times. The protein concentration was determined using a BCA protein Assay Kit (Beyotime, China). Cell lysates containing total protein (20-120 μg) were separated by SDS-PAGE and then transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Germany) by the wet transfer method. Membranes were blocked with 5% skim milk at room temperature and then incubated with the indicated primary antibodies against PARP-1 (sc-7150, Santa Cruz), Bax (sc-526, Santa Cruz), Bcl-2 (sc-492, Santa Cruz), caspase-3 (9661, Cell Signaling Technology), SQSTM1 (sc-25572, Santa Cruz), LC3 (L7543, Sigma-Aldrich), GAPDH (AC002, ABclonal Technology), β-actin (AC004, ABclonal Technology), JNK (9252, Cell Signaling Technology) or p-JNK (9255, Cell Signaling Technology) on a swing bed at 4 °C overnight. After washing three times with TBST, the blots were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (ABclonal Technology) for 1 h on a swing bed at room temperature. Each immune complex was detected by Enhanced Chemiluminescence (ECL) Substrate (WESTAR Supernova, Cyanogen) and visualized by the ChemiDoc TM MP System (Bio-Rad).
Morphological apoptosis
Morphological changes induced by apoptosis were detected by Hoechst staining. After exposure to RA, cell slides were stained with Hoechst 33258 (Beyotime, China) for 5 min at room temperature. After washing, slides were observed using the FSX100 Bio Imaging Navigator (Olympus, Japan) to detect the morphology of chromatin and nuclei.
Transmission electron microscopy observation Autophagosome formation was visualized by transmission electron microscopy (TEM) as previously described [31] . Cells (1×10 5 cells/well) were seeded in 6-well plates and allowed to attach. After treatment with RA for 24 h, cells were trypsinized and then fixed with 2.5% glutaraldehyde in phosphate buffer overnight at 4 °C. After a dehydrating step using ethanol and acetone, cells were post-fixed with 1% osmium tetroxide for 30 min. Subsequently, the cells were infiltrated with araldite, polymerized, sectioned at a thickness of 60 nm, and stained with lead citrate-uranyl acetate. Ultrathin sections were observed by a H-7650 transmission electron microscope (Hitachi, Japan).
Annexin V-FITC and PI assay for flow cytometry
The apoptotic rate of glioblastoma cells was detected using the Annexin V-FITC Apoptosis Detection Kit (BD Bioscience, USA) according to the manufacturer's instructions. Cells (2×10 5 cells/well) were seeded in 6-well dishes with the desired stimuli. The harvested cells were suspended in the 1X binding buffer, and stained using Annexin V-FITC and propidium iodide (PI) for 20 min. Next, the treated cells were assessed using an Accuri C6 flow cytometer (BD Bioscience, USA).
Measurement of ROS
ROS levels were detected using a ROS kit (Beyotime, China) according to the manufacturer's instructions. Briefly, 5×10 5 cells were plated on Poly-D-lysine (PDL)-coated slides in 35-mm dishes. Following complete attachment, the cells were treated with the desired stimuli for 24 h. Next, the cells were harvested and stained with 10 μM DCFH-DA for 20 min at 37 °C. The slides were washed three times with DMEM free of FBS to thoroughly eliminate unconjugated probes, and were visualized using a FSX100 Bio Imaging Navigator (Olympus, Japan).
Detection of caspase-3 activity
Caspase-3 activity was detected using the Caspase-3 Activity Assay Kit (Beyotime, China) according to the manufacturer's instructions. Briefly, cell lysates were prepared after exposing cells to the desired stimuli. The activity of caspase-3 was measured using substrate the Ac-DEVD-pNA (acetyl-Asp-Glu-ValAsp p-nitroanilide). The release of pNA cleaved by caspase-3 was quantified by measuring the absorbance at 405 nm using a microplate reader (M200; TECAN, Japan).
Immunohistochemical staining
In brief, 5-μm paraffin-embedded sections of tumor tissues were regularly deparaffinized and incubated in H 2 O 2 for 10 min. After washing, sections were microwaved and allowed to cool to room temperature. All primary antibodies were rabbit polyclonal antibodies: caspase-3 (9661, Cell Signaling Technology) and Ki67 (A2094, ABclonal). Cell slides were incubated with the primary antibodies at 4 °C overnight. Sections were incubated with the secondary antibody (PV6001, ZSGB-BIO) at 37 °C for 30 min and rendered using the DAB kit (ZLI-9017, ZSGB-BIO) for 10 min. After intensive washing, slides were counterstained with hematoxylin for one minute. Subsequently, the slides were dehydrated, blocked and observed using Moticam 3000 (Motic, USA) at a high-power magnification (400X). All pictures were analyzed with Image-Pro Plus 6.0. The integral optical density (IOD) was selected, and six random high-power magnification fields were chosen for the mean value analysis to represent the relative protein expression levels. 
In vivo xenograft assay

Statistical analysis
Data from independent experiments were expressed as the mean ± SD. Statistical analysis between groups was performed using Student's t test or one-way ANOVA as appropriate followed by multiple comparisons performed with a post hoc Bonferroni test (SPSS version 18.0). P < 0.05 was considered statistically significant (*).
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Results
RA reduces GBM cell viability
To investigate the potential effect of RA on glioblastoma in vitro, four cultured GBM cell lines (G112, U87, U251 and T98) were exposed to the indicated concentrations of RA for 24 h or 48 h. The MTT assay results demonstrated that RA significantly reduced cell viability in a dose-and timedependent manner relative to the DMSO-treated controls (Fig. 1B) . These results indicate that RA inhibited the viability of GBM cells.
RA inhibits the invasion and migration of GBM cells
We next investigated whether RA exhibited antiinvasive and anti-migratory effects in GBM cells; thus, wound healing and Transwell assays were performed at different concentrations and time points. Following exposure to RA, the Transwell assays demonstrated that the cells presented considerably reduced invasive potential compared to the DMSO control group (Fig. 2A) . Furthermore, RA-treated cells presented slower wound closure capacity than did the DMSO control group, as shown in Fig. 2B and 2C. These results indicate that RA inhibited the migration and invasion of GBM in vitro.
RA induces apoptosis in GBM cells
To determine whether apoptosis is responsible for the inhibition of GBM cell growth by RA, we conducted the Hoechst staining assay on U251 and T98 cells. Fig. 3A shows chromatin condensation and DNA fragmentation, which are morphological characteristics of apoptosis [32] . Furthermore, we used the Annexin V-FITC/PI double staining method and flow cytometry to examine the apoptotic rate. As shown in Fig. 3B , RA exposure for 24 h led to a significantly increased apoptotic rate in U251 and T98 cells. Furthermore, the western blotting results (Fig. 3C ) demonstrated that treatment using 4 µM RA for 24 h, triggered 
apoptosis, and the levels of the key apoptosis activator cleaved caspase-3 were increased. Full-length poly (ADP-ribose) polymerase 1 (PARP 1) is cleaved by caspase-3 from 116 kDa into an 89 kDa fragment [33] . As shown in Fig. 3C , PARP 1 cleavage was clearly detected in RA-treated GBM cells. Next, we observed that RA treatment increased the expression of proapoptotic Bax and decreased the level of anti-apoptotic Bcl-2 (Fig. 3C) . To examine whether RA-induced apoptosis was caspase-dependent, we introduced the pan-caspase inhibitor z-VAD-fmk. As shown in Fig. 3D , combined treatment with z-VAD-fmk rescued RA-induced cell death. Lower activation of caspase-3 and PARP 1 cleavage in the combined group were detected compared to that observed in groups that received RA treatment alone (Fig. 3E) . Collectively, these results indicate that RA induced apoptotic cell death in GBM cells. 
ROS/JNK signaling is involved in RA-induced apoptosis in GBM cells
As RA induced cell death by apoptosis activation in cultured cells, we next investigated the underlying molecular mechanisms of apoptosis in cultured cells. ROS has been demonstrated to be involved in the regulation of apoptosis [28] , and under stressful conditions, sustained JNK phosphorylation correlates with apoptosis [24, 25] . Consistent with previous studies, our results demonstrated that RA treatment could lead to the massive production of intracellular ROS (Fig. 4A) , and increase the level of p-JNK (Fig. 4B) . Conversely, pretreatment with the antioxidant NAC (5 mM) could rescue cell viability by scavenging ROS (Fig. 4C and 4D) . Next, the flow cytometry results (Fig. 4E ) demonstrated that the ROS scavenger NAC significantly decreased the RA-induced apoptotic rate in GBM cells. In addition, we observed that caspase-3 (Fig. 4G) . Next, we examined changes in p-JNK in response to the combination of NAC and RA to investigate the involvement of ROS/JNK signaling in RA-induced apoptosis. As shown in Fig. 4F , after eliminating ROS by NAC, the levels of p-JNK in the combined treatment group with NAC were much lower than those observed in the U251 and T98 cells that received RA alone. Together, these results indicate that RA-triggered apoptosis in GBM cells was dependent on ROS/JNK signaling.
RA induces autophagy in GBM cells, and the suppression of autophagy enhances RAinduced apoptosis
To determine whether other cell death pathways are involved in GBM cells receiving RA treatment, we investigated the level of autophagy, which is regarded as type II programmed cell death [34] . The TEM results (Fig. 5A ) demonstrated that after exposure to RA, autophagosomes were clearly observed, as indicated by the red arrows. The conversion of microtubule-associated protein light chain 3 I (LC3-I) to LC3-II serves as a marker for the activation of autophagy signaling [35] , and SQSTM1, an autophagic substrate, is degraded during the autophagic process [36, 37] . As shown in Fig. 5B , the level of LC3-II in U251 and T98 cells increased and was accompanied by the degradation of SQSTM1. Overwhelming evidence suggests that autophagy is a double-edged sword in carcinogenesis, either preventing tumor initiation or sustaining tumor metabolism [38] . To confirm the exact role of RA-induced autophagy in GBM cells, we examined cell viability in the presence or absence of an inhibitor of class III PI3K, 3-MA [31, 35] , which is a commonly used autophagy inhibitor. Interestingly, inhibition of autophagy exacerbated glioma cell death (Fig. 5C ). As expected, the level of cleaved caspase-3 was up-regulated after the inhibition of autophagy. Thus, U251 cell fate tend to shift toward apoptosis (Fig. 5D) . Together, these results reveal that the inhibition of RA-induced autophagy enhanced apoptosis in GBM cells.
RA inhibits GBM growth in vivo
To verify the efficacy of RA in vivo, we performed tumor xenografts in the nude mouse model. The average tumor weight and volume in the RA-treated groups decreased after 7 days compared to that of the PBS-treated group (Fig. 6A and 6B ). RA simultaneously decreased the level of the key proliferation marker Ki67 in U251-derived xenografts (Fig. 6H) . As expected, no obvious decrease in the body weights of any tumor-bearing mice was observed (Fig. 6C  and 6D ). Next, RA increased the activation of caspase-3, conversion of LC3-I to LC3-II and phosphorylation of JNK (Fig. 6E, 6F and 6G ) compared to the levels observed in the PBStreated group. Furthermore, i m m u n o h i s t o c h e m i c a l staining demonstrated that RA induced apoptosis in vivo by elevating the level of cleaved caspase-3 (Fig. 6H) . Taken together, our in vivo studies further support the inhibitory roles of RA on GBM in vitro.
Discussion
Despite decades of efforts, GBM remains the greatest challenge in the neurosurgical field, as it exhibits refractory recurrence and a poor prognosis. Advanced therapeutic strategies require further exploration. Excessive growth and high infiltration are 
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associated with glioma aggression and invasion, which are potential therapeutic targets for eradicating glioblastoma. Tumor cells acquire growth signaling autonomy to attain limitless growth, which results in an imbalance of homeostasis [4] . Thus, regimens that can significantly impede the growth of GBM are in urgent need. RA exerts inhibitory effects on cell viability and induces apoptotic cell death in various cancer types [10, 11] . Consistent with those findings, our results demonstrated that RA markedly suppressed the viability of GBM cells (Fig. 1) . Another well-known characteristic of glioblastoma is the infiltration of adjacent normal brain parenchyma. Cells in the infiltrative region render the tumor surgically incurable and mediate post-operative recurrence of the primary tumor. Therefore, the invasion and migration of glioblastoma cells have become important research topics, and anti-invasive and anti-migratory treatment strategies will be highly valuable to GBM patients. Xue et al. demonstrated that RA inhibited migration and invasion in low differentiated human gastric cancer BGC-823 cell line in a dose dependent manner [10] . Our results showed that RA significantly reduced the invasive and migratory abilities of GBM cells (Fig. 2) , demonstrating that RA could potentially improve the prognosis of GBM patients. Matrix metalloproteinases (MMPs) comprise a family of zinc-dependent endopeptidases that can degrade the extracellular matrix, thus promoting the invasion and metastasis of cancer cells [39] . Strong correlations have been reported between elevated levels of MMPs (MMP2 and MMP9) and tumor cell invasiveness in human gliomas [40] . However, invasion and metastasis in glioblastoma are multi-step processes with complex molecular mechanisms. Thus, further exploration of the effect of RA on MMPs in glioblastoma is required.
ROS plays a pivotal role in the maintenance of cell homeostasis. Nonetheless, several reports have demonstrated that excessive accumulation of intracellular ROS is usually associated with apoptosis in cancer cells [41, 42] . Li et al. showed that RA exerted a synergistic effect with cisplatin on inducing ROS production in hepatocellular carcinoma [43] . Liu et al. reported that oxidative stress occurred after exposure to a concentration of 300 μM H 2 O 2 and caspase-3-involved apoptosis was detected in the human glioma U251 cell line [44] . Consistent with previous studies, we observed that RA treatment triggered apoptosis signaling in GBM cells (Fig. 3) . The Bcl-2 family plays a key role in apoptosis, in which Bax (proapoptotic gene) and Bcl-2 (anti-apoptotic gene) are influential factors for the downstream activation of caspase protein [45, 46] . Consistently, we observed the downregulation of Bcl-2 and upregulation of Bax in a time-dependent manner after RA treatment. Intriguingly, the FACS results demonstrated that a small portion of PI-positive cells could be detected after RA exposure (Fig. 3B) . Simultaneously, the inhibition of RA-induced apoptosis by z-VAD-fmk can partially rescue PI-positive cells as shown in Fig. 4E . Based on these findings, we conclude that RA induced cell death in glioblastoma cells occurs primarily but not exclusively via apoptosis. Other cell death signaling may be involved and requires further investigation.
MAPK signaling is frequently activated in several cancers and is responsible for apoptosis [47] . Baik et al. reported that cordycepin induced apoptosis through an extrinsic pathway and the activation of p38 MAPK in U87 cells [48] . Teng et al. demonstrated that p38 MAPK is activated during RA-induced apoptosis in the human gastric cancer SGC-7901 cell line [49] . Herein, massive ROS production induced by RA was observed in GBM cells using a DCFH-DA fluorescent probe. Similarly, we observed that sustained p-JNK, which is closely related to stressful stimuli, regulated RA-induced apoptosis in glioblastoma. Conversely, ROS scavenging by the antioxidant NAC partially rescued cell viability, inhibited p-JNK, and decreased caspase-3 activation (Fig. 4) . Together, these results demonstrate that ROS/JNK signaling is involved in RA-induced apoptosis in GBM cells, and may provide potential strategies against malignant gliomas. Autophagy represents an important cellular-physiologic response. The interplay between autophagy and apoptosis is complex and has been the focus of research [50, 51] .In most reports, autophagy has been demonstrated to protect cancer cells from apoptosis by providing nutrition and inducing resistance [52, 53] . However, excessive autophagy can lead to caspase-independent cell death. Our results revealed that RA induced autophagy signaling (Fig. 5) . Since autophagy plays dual roles during tumor progression, we inhibited autophagy by 3-MA. Interestingly, after blocking autophagy, the viability of U251 cells decreased in the combination therapy group, exhibiting increased apoptosis. These results indicate that autophagy may protect glioblastoma cells from RA-induced apoptosis and provide evidence for the combined use of RA and an autophagy inhibitor as a novel strategy for GBM therapy.
The relationship between RA-induced apoptosis and autophagy is illustrated in Fig. 7 . RA is the primary ingredient of a famous Chinese patent medicine. Luan et al. developed a superior method for the analysis and quantification of RA in rat plasma by intravenous injection of a concentration of 0.75 mg/kg body weight [9] . Wang et al. investigated the plasma concentration of RA by injecting 0.5 mg/kg, 1.5 mg/kg, and 4.5 mg/kg in mice. After 10 days, the RA injection was demonstrated to exert a significant inhibitory effect on tumor growth with an obvious dosage-effect relationship [54] . Thus, we chose intraperitoneal dosages of 1 mg/kg and 2 mg/kg to investigate the effects of RA on glioblastoma in vivo, and the results were consistent with our in vitro results. Nevertheless, the therapeutic use of RA in GBM patients may be warranted under a strict protocol in the future.
Conclusion
Our study demonstrated a novel anti-glioma effect of RA mediated by inducing the ROS/ JNK cascade in glioblastoma. The ROS/JNK cascade was involved in RA-induced apoptosis and contributed to RA-induced cell death. Moreover, apoptotic cell death could be enhanced by blocking RA-induced autophagy. To date, no remarkable progress has been made in the development of effective strategies for eliminating glioblastoma. Thus, the results of this study may shed new light on the understanding and treatment of glioblastoma. 
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